In short, RBM15‐mediated m6A modification enhanced SRSF1 stability, and SRSF1 promoted ATP7B alternative splicing to inhibit cuproptosis, thereby promoting NSCLC cell proliferation and tumor growth. The gene discussed is ATP7B; the disease is neoplasm.